BBB | Blood–brain barrier |
CAR | Chimeric antigen receptor |
CTX | Chemotherapy |
DFMO | Difluoromethylornithine |
DIPG | Diffuse intrinsic pontine glioma |
DMG | Diffuse midline glioma |
FDA | Food and Drug Administration |
GD2 | Disialoganglioside-2 |
H3 | Histone 3 |
NOS | Not otherwise specified |
OS | Overall survival |
PFS | Progression-free survival |
QoL | Quality of life |
RT | Radiotherapy |
TILs | Tumor-infiltrating lymphocytes |
WHO | World Health Organization |